Europe's Push for Unified Drug Access
EMA's head Emer Cooke advocates for the EU to increase its involvement in drug accessibility, currently managed by member states. Speaking in Barcelona, Cooke emphasized the need for more European collaboration to streamline access to newly approved medications, hinting at a broader continental role in pharmaceuticals.
- Country:
- Spain
Head of the European Medicines Agency, Emer Cooke, has called on the European Union to enhance its role in securing access to newly approved drugs. Currently, member states independently manage this area, but Cooke suggests a centralized approach could streamline processes and benefits.
Speaking at the Reuters Pharma Europe 2026 event in Barcelona, Cooke insisted, 'We need more Europe.' Her comment underscores the call for greater EU involvement and collaboration in pharmaceutical regulation and access across member countries.
The push for a unified strategy reflects the need for greater efficiency and uniformity in drug accessibility throughout the European Union, aiming to offer better health solutions across the continent.
(With inputs from agencies.)
ALSO READ
Global Health Concerns: Acute Hunger, Ebola, Virus Outbreaks, and Pharmaceutical Updates
Alembic Pharmaceuticals Posts 29% Profit Surge in Q4
Alembic Pharmaceuticals Secures USFDA Nod for Prostate Cancer Drug
Legal and Health Challenges Amidst Hantavirus Outbreak and Pharmaceutical Updates
GlaxoSmithKline Pharmaceuticals Ltd Posts Strong Q4 Profits
Google News